BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24339914)

  • 1. PADI2 is significantly associated with rheumatoid arthritis.
    Chang X; Xia Y; Pan J; Meng Q; Zhao Y; Yan X
    PLoS One; 2013; 8(12):e81259. PubMed ID: 24339914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in peptidylarginine deiminase associate with rheumatoid arthritis in diverse Asian populations: evidence from MyEIRA study and meta-analysis.
    Too CL; Murad S; Dhaliwal JS; Larsson P; Jiang X; Ding B; Alfredsson L; Klareskog L; Padyukov L
    Arthritis Res Ther; 2012 Nov; 14(6):R250. PubMed ID: 23164236
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Guzmán-Guzmán IP; Ramírez-Vélez CI; Falfán-Valencia R; Navarro-Zarza JE; Gutiérrez-Pérez IA; Zaragoza-García O; Ramírez M; Castro-Alarcón N; Parra-Rojas I
    Front Immunol; 2021; 12():718246. PubMed ID: 34421923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Factors in PAD2 (
    Nava-Quiroz KJ; Rojas-Serrano J; Pérez-Rubio G; Buendia-Roldan I; Mejía M; Fernández-López JC; Rodríguez-Henríquez P; Ayala-Alcantar N; Ramos-Martínez E; López-Flores LA; Del Ángel-Pablo AD; Falfán-Valencia R
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The amount of citrullinated proteins in synovial tissue is related to serum anti-cyclic citrullinated peptide (anti-CCP) antibody levels.
    Olivares-Martínez E; Hernández-Ramírez DF; Núñez-Álvarez CA; Cabral AR; Llorente L
    Clin Rheumatol; 2016 Jan; 35(1):55-61. PubMed ID: 26255191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidylarginine Deiminase 2 Gene Polymorphisms in Subjects with Periodontitis Predispose to Rheumatoid Arthritis.
    Massarenti L; Enevold C; Damgaard D; Hansen PR; Frisch M; Ødum N; Jacobsen S; Nielsen CH
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of mRNA for peptidylarginine deiminase type 2 and type 4 in bone marrow CD34+ cells in rheumatoid arthritis.
    Nagai T; Matsueda Y; Tomita T; Yoshikawa H; Hirohata S
    Clin Exp Rheumatol; 2018; 36(2):248-253. PubMed ID: 29148420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association between the synovial expression of cyclic citrullinated peptide and susceptibility variants of HLA-DRB1 shared epitope alleles and PADI 4 gene single nucleotide polymorphisms in patients with rheumatoid arthritis].
    Li HB; Tie N; Jia YF; Shi L; Su Y; Zhang GZ; Wang Y; Bai LJ; Zhao J; Wang J; Xiao Z
    Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(23):1607-11. PubMed ID: 22944128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptidylarginine deiminase type 4: identification of a rheumatoid arthritis-susceptible gene.
    Yamada R; Suzuki A; Chang X; Yamamoto K
    Trends Mol Med; 2003 Nov; 9(11):503-8. PubMed ID: 14604829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating a pathogenic role for TXNDC5 in rheumatoid arthritis.
    Chang X; Zhao Y; Yan X; Pan J; Fang K; Wang L
    Arthritis Res Ther; 2011 Jul; 13(4):R124. PubMed ID: 21801346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study.
    Bang SY; Han TU; Choi CB; Sung YK; Bae SC; Kang C
    Arthritis Res Ther; 2010; 12(3):R115. PubMed ID: 20537173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice.
    Suzuki A; Kochi Y; Shoda H; Seri Y; Fujio K; Sawada T; Yamada R; Yamamoto K
    BMC Musculoskelet Disord; 2016 May; 17():205. PubMed ID: 27150598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of PADI4 in synovium of rheumatoid arthritis.
    Chang X; Zhao Y; Sun S; Zhang Y; Zhu Y
    Rheumatol Int; 2009 Oct; 29(12):1411-6. PubMed ID: 19199100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PADI4 haplotypes in association with RA Mexican patients, a new prospect for antigen modulation.
    Zavala-Cerna MG; Gonzalez-Montoya NG; Nava A; Gamez-Nava JI; Moran-Moguel MC; Rosales-Gomez RC; Gutierrez-Rubio SA; Sanchez-Corona J; Gonzalez-Lopez L; Davalos-Rodriguez IP; Salazar-Paramo M
    Clin Dev Immunol; 2013; 2013():383681. PubMed ID: 24454473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population.
    Burr ML; Naseem H; Hinks A; Eyre S; Gibbons LJ; Bowes J; Wilson AG; Maxwell J; Morgan AW; Emery P; Steer S; Hocking L; Reid DM; Wordsworth P; Harrison P; Thomson W; Worthington J; ; ; Barton A
    Ann Rheum Dis; 2010 Apr; 69(4):666-70. PubMed ID: 19470526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis.
    Harris ML; Darrah E; Lam GK; Bartlett SJ; Giles JT; Grant AV; Gao P; Scott WW; El-Gabalawy H; Casciola-Rosen L; Barnes KC; Bathon JM; Rosen A
    Arthritis Rheum; 2008 Jul; 58(7):1958-67. PubMed ID: 18576335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citrullination by peptidylarginine deiminase in rheumatoid arthritis.
    Suzuki A; Yamada R; Yamamoto K
    Ann N Y Acad Sci; 2007 Jun; 1108():323-39. PubMed ID: 17893996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PADI4 gene does not contribute to genetic susceptibility to rheumatoid arthritis in Chinese Han population.
    Chen R; Wei Y; Cai Q; Duan S; Ren D; Shen J; He D; Fang M; Lv K; Cheng N; Sun S
    Rheumatol Int; 2011 Dec; 31(12):1631-4. PubMed ID: 20563870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis.
    Lee YH; Rho YH; Choi SJ; Ji JD; Song GG
    Rheumatol Int; 2007 Jul; 27(9):827-33. PubMed ID: 17265154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PADI4 and HLA-DRB1 are genetic risks for radiographic progression in RA patients, independent of ACPA status: results from the IORRA cohort study.
    Suzuki T; Ikari K; Yano K; Inoue E; Toyama Y; Taniguchi A; Yamanaka H; Momohara S
    PLoS One; 2013; 8(4):e61045. PubMed ID: 23577190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.